Steven Jungles
Overview
Steven Jungles received $1M in total compensation, including $396K in salary, at Inozyme Pharma in 2021.
Source: SEC filing on April 27, 2022.
Related executives
We found seven more executives who work or worked at Inozyme Pharma.
Douglas Treco
Inozyme Pharma
Chief Executive Officer
Axel Bolte
Inozyme Pharma
Chief Executive Officer
Matthew Winton
Inozyme Pharma
Chief Operating Officer
Sanjay Subramanian
Inozyme Pharma
Chief Financial Officer
Henric Bjarke
Inozyme Pharma
Chief Operating Officer
Deborah Wenkert
Inozyme Pharma
Chief Medical Officer
Pedro Huertas
Inozyme Pharma